Bioactives and Nanocarriers: Merging Frontiers in Cancer Therapy
- 8 July 2025
- journal article
- review article
- Published by Wiley in Chemistry – An Asian Journal
- Vol. 20 (18) , e00293
Abstract
In 2020, cancer was accredited for 10 million deaths, responsible for nearly one in six deaths worldwide. Nanomedicine holds significant promise for revolutionizing diagnosis and prognosis of cancer. Conventional cancer therapies including surgery, radiation therapy, and chemotherapy are chosen based on type, location, stage of cancer, and the patient's health. They typically aim to remove or control growth of cancerous cells. However, each of the therapies has its advantages, shortcomings, and side effects. To overcome this, the focus is shifting toward targeted therapy that uses bioactive molecules designed to exclusively attack cancer cells, sparing healthy ones. This approach involves engineering nanomaterials to create drug delivery systems with unique properties and functionalities. Delivering drugs via appropriate nanocarriers through surface modifications enable them to target the tumor cells. In this aspect, quantum dots, carbon nanotubes, carbon dots under inorganic nanocarriers and liposomes, dendrimers, and others belonging to organic nanocarriers are being widely used to deliver bioactives in diagnosis and treatment of cancers. This bioactive in targeted drug delivery via nanoscale miniature formulation is gaining acclaim for its potential to revolutionize cancer treatment. This review highlighted the works of various nanocarriers used as delivery vehicles that encapsulate bioactive compounds for targeted delivery to cancer cells.Keywords
This publication has 99 references indexed in Scilit:
- Preparation and Evaluation of Polyethylene Glycol Conjugated Polyethylene Imine‐Coated Magnetic Nanoparticles for Paclitaxel Delivery to Cervical Cancer CellsPolymers for Advanced Technologies, 2024
- Recent progress and drug delivery applications of surface-functionalized inorganic nanoparticles in cancer therapyJournal of Pharmaceutical Investigation, 2023
- Review on metal nanoparticles as nanocarriers: current challenges and perspectives in drug delivery systemsEmergent Materials, 2022
- Development of High‐Drug‐Loading NanoparticlesChempluschem, 2020
- Methods for determining bioavailability and bioaccessibility of bioactive compounds and nutrients2019
- Nanocarriers for drug delivery applicationsEnvironmental Chemistry Letters, 2018
- Engineered Nanoparticles for Drug Delivery in Cancer TherapyAngewandte Chemie International Edition, 2014
- pH-Responsive Single Walled Carbon Nanotube Dispersion for Target Specific Release of Doxorubicin to Cancer CellsMacromolecular Bioscience, 2014
- Carbon-based drug delivery carriers for cancer therapyArchives of Pharmacal Research, 2013
- Estimation of an optimal radiotherapy utilization rate for melanomaCancer, 2004